1. Home
  2. GKOS vs PRIM Comparison

GKOS vs PRIM Comparison

Compare GKOS & PRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$126.04

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Primoris Services Corporation

PRIM

Primoris Services Corporation

HOLD

Current Price

$98.43

Market Cap

6.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
PRIM
Founded
1998
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Water Sewer Pipeline Comm & Power Line Construction
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.7B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
GKOS
PRIM
Price
$126.04
$98.43
Analyst Decision
Strong Buy
Buy
Analyst Count
12
15
Target Price
$126.92
$155.20
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
0.19%
EPS Growth
N/A
51.66
EPS
N/A
0.32
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$9.92
Revenue Next Year
$27.43
$8.80
P/E Ratio
N/A
$295.31
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$73.90
52 Week High
$148.11
$205.50

Technical Indicators

Market Signals
Indicator
GKOS
PRIM
Relative Strength Index (RSI) 53.33 35.56
Support Level $94.16 N/A
Resistance Level $147.43 $133.04
Average True Range (ATR) 7.18 8.83
MACD 1.01 -1.75
Stochastic Oscillator 91.26 23.38

Price Performance

Historical Comparison
GKOS
PRIM

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.

Share on Social Networks: